New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Potential therapy target for cardiac arrhythmias found in SK2 channels

Potential therapy target for cardiac arrhythmias found in SK2 channels

byUniversity of ArizonaCredit: Unsplash/CC0 Public DomainA new study by researchers at the University of Arizona College of Medicine–Phoenix and the University of California Davis Health identif
Cardiovascular Diseases October 21,2024
Potential therapy target for cardiac arrhythmias found in SK2 channels

Potential therapy target for cardiac arrhythmias found in SK2 channels

byUniversity of ArizonaCredit: Unsplash/CC0 Public DomainA new study by researchers at the University of Arizona College of Medicine–Phoenix and the University of California Davis Health identif
Cardiovascular Diseases October 21,2024
Long COVID: Study finds lithium aspartate at low doses is ineffective, but higher doses may be promising

Long COVID: Study finds lithium aspartate at low doses is ineffective, but higher doses may be promising

byUniversity at BuffaloCredit: Andrea Piacquadio from PexelsA small University at Buffalo clinical trial has found that at low doses, lithium aspartate is ineffective in treating the fatigue and
Public Health & Prevention October 21,2024
Long COVID: Study finds lithium aspartate at low doses is ineffective, but higher doses may be promising

Long COVID: Study finds lithium aspartate at low doses is ineffective, but higher doses may be promising

byUniversity at BuffaloCredit: Andrea Piacquadio from PexelsA small University at Buffalo clinical trial has found that at low doses, lithium aspartate is ineffective in treating the fatigue and
Public Health & Prevention October 21,2024
Researchers identify new therapeutic approach to preventing cancer from spreading to the brain

Researchers identify new therapeutic approach to preventing cancer from spreading to the brain

byMcMaster UniversityCredit: CC0 Public DomainIn a studypublishedin the journalCell Reports Medicine, researchers Sheila Singh and Jakob Magolan discovered a critical vulnerabi
Oncology October 21,2024
Researchers identify new therapeutic approach to preventing cancer from spreading to the brain

Researchers identify new therapeutic approach to preventing cancer from spreading to the brain

byMcMaster UniversityCredit: CC0 Public DomainIn a studypublishedin the journalCell Reports Medicine, researchers Sheila Singh and Jakob Magolan discovered a critical vulnerabi
Oncology October 21,2024
Synthetic peptide acts as molecular shield to prevent SARS-CoV-2 from infecting cells

Synthetic peptide acts as molecular shield to prevent SARS-CoV-2 from infecting cells

by Julia Moióli,FAPESPThe figure shows the interaction between the synthetic ACE2 peptide (yellow) and the SARS-CoV-2 spike protein. The spikes of the original viral strain from Wuhan and the om
Public Health & Prevention October 21,2024
Synthetic peptide acts as molecular shield to prevent SARS-CoV-2 from infecting cells

Synthetic peptide acts as molecular shield to prevent SARS-CoV-2 from infecting cells

by Julia Moióli,FAPESPThe figure shows the interaction between the synthetic ACE2 peptide (yellow) and the SARS-CoV-2 spike protein. The spikes of the original viral strain from Wuhan and the om
Public Health & Prevention October 21,2024
Precision breast cancer trial shows improved treatment by tumor subtype

Precision breast cancer trial shows improved treatment by tumor subtype

byUniversity of California, San FranciscoEfficacy of Dato-DXd + durvalumab treatment. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-03267-1Despite recent advances in the trea
Oncology October 21,2024
Precision breast cancer trial shows improved treatment by tumor subtype

Precision breast cancer trial shows improved treatment by tumor subtype

byUniversity of California, San FranciscoEfficacy of Dato-DXd + durvalumab treatment. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-03267-1Despite recent advances in the trea
Oncology October 21,2024
Clinical trial finds new drug significantly extends lives of breast cancer patients

Clinical trial finds new drug significantly extends lives of breast cancer patients

byLudwig Maximilian University of MunichKaplan–Meier analysis of key efficacy endpoints in patients with baseline BMs. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-03261-7Pa
Oncology October 21,2024
Clinical trial finds new drug significantly extends lives of breast cancer patients

Clinical trial finds new drug significantly extends lives of breast cancer patients

byLudwig Maximilian University of MunichKaplan–Meier analysis of key efficacy endpoints in patients with baseline BMs. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-03261-7Pa
Oncology October 21,2024
Experts release the latest guide for systematic reviews of preclinical research

Experts release the latest guide for systematic reviews of preclinical research

byRadboud UniversityCredit: Unsplash/CC0 Public DomainA new publication inNature Reviews Methods Primersprovides essential guidance for conducting rigorous systematic reviews on stud
Breakthroughs October 21,2024
Experts release the latest guide for systematic reviews of preclinical research

Experts release the latest guide for systematic reviews of preclinical research

byRadboud UniversityCredit: Unsplash/CC0 Public DomainA new publication inNature Reviews Methods Primersprovides essential guidance for conducting rigorous systematic reviews on stud
Breakthroughs October 21,2024
Reducing sitting by about 40 minutes daily may prevent back pain, research suggests

Reducing sitting by about 40 minutes daily may prevent back pain, research suggests

byUniversity of TurkuChange in back pain intensity on a scale from 0 to 10. The blue bars represent individuals in the intervention group that reduced sitting and the red bars represent the cont
Orthopedics & Sports medicine October 21,2024
Reducing sitting by about 40 minutes daily may prevent back pain, research suggests

Reducing sitting by about 40 minutes daily may prevent back pain, research suggests

byUniversity of TurkuChange in back pain intensity on a scale from 0 to 10. The blue bars represent individuals in the intervention group that reduced sitting and the red bars represent the cont
Orthopedics & Sports medicine October 21,2024
Event-free survival extended with long-term finerenone in heart failure

Event-free survival extended with long-term finerenone in heart failure

by Elana GotkineLong-term treatment with finerenone is estimated to extend event-free survival among people with heart failure with mildly reduced or preserved ejection fraction, according to a brief
Cardiovascular Diseases October 21,2024
Event-free survival extended with long-term finerenone in heart failure

Event-free survival extended with long-term finerenone in heart failure

by Elana GotkineLong-term treatment with finerenone is estimated to extend event-free survival among people with heart failure with mildly reduced or preserved ejection fraction, according to a brief
Cardiovascular Diseases October 21,2024
GLP-1 weight-loss meds could interfere with endoscopy, colonoscopy

GLP-1 weight-loss meds could interfere with endoscopy, colonoscopy

by Ernie MundellFood left in the stomach or stool left in the bowel can impede a doctor's ability to successfully perform an endoscopy or colonoscopy.Now, research finds this scenario is more like
Diabetes & Endocrinology October 21,2024
GLP-1 weight-loss meds could interfere with endoscopy, colonoscopy

GLP-1 weight-loss meds could interfere with endoscopy, colonoscopy

by Ernie MundellFood left in the stomach or stool left in the bowel can impede a doctor's ability to successfully perform an endoscopy or colonoscopy.Now, research finds this scenario is more like
Diabetes & Endocrinology October 21,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com